Document is current
Any future updates will be listed below
-
Authors
Arkell, Thomas R. https://orcid.org/0000-0002-8559-6995
Abelev, Sarah V.
Mills, Llewellyn
Suraev, Anastasia
Arnold, Jonathon C.
Lintzeris, Nicholas
McGregor, Iain S.
- License Information
-
More Information
Article History
Received: 11 July 2023
Accepted: 10 August 2023
First Online: 6 September 2023
Declarations
:
: This study was approved by the Sydney University Human Research Ethics Committee (2018/544). In order to begin the survey, participants were asked to read a linked Participant Information Statement and to tick a check box giving consent for their data to be used in the study.
: Not applicable.
: Prof Lintzeris reports grants from the Australian National Health and Medical Research Council (NHMRC) during the conduct of the study, and research grants from Camurus and Indivior for unrelated work. A/Prof Arnold and Prof McGregor report grants from NHMRC and grants from Lambert Initiative for Cannabinoid Therapeutics during the conduct of the study for projects unrelated to the submitted work; Dr. McGregor has patents to WO2018107216A1, WO2017004674A1, and WO2011038451A1 issued and licensed. A/Prof Arnold and Prof McGregor have patents to AU2017904438, AU2017904072, and AU2018901971 pending. The other authors declare that they have no competing interests.
